183 related articles for article (PubMed ID: 10454551)
21. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
22. eIF4G dramatically enhances the binding of eIF4E to the mRNA 5'-cap structure.
Haghighat A; Sonenberg N
J Biol Chem; 1997 Aug; 272(35):21677-80. PubMed ID: 9268293
[TBL] [Abstract][Full Text] [Related]
23. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
Hara K; Yonezawa K; Weng QP; Kozlowski MT; Belham C; Avruch J
J Biol Chem; 1998 Jun; 273(23):14484-94. PubMed ID: 9603962
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of eIF-4E positively regulates formation of the eIF-4F translation initiation complex following DNA damage.
Zhang Y; Li Y; Yang DQ
Biochem Biophys Res Commun; 2008 Feb; 367(1):54-9. PubMed ID: 18164262
[TBL] [Abstract][Full Text] [Related]
25. Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway.
Lin TA; Kong X; Saltiel AR; Blackshear PJ; Lawrence JC
J Biol Chem; 1995 Aug; 270(31):18531-8. PubMed ID: 7629182
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism.
Greenberg VL; Zimmer SG
Oncogene; 2005 Jul; 24(30):4851-60. PubMed ID: 15897904
[TBL] [Abstract][Full Text] [Related]
27. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control.
Polakiewicz RD; Schieferl SM; Gingras AC; Sonenberg N; Comb MJ
J Biol Chem; 1998 Sep; 273(36):23534-41. PubMed ID: 9722592
[TBL] [Abstract][Full Text] [Related]
28. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation.
Lang CH; Frost RA; Nairn AC; MacLean DA; Vary TC
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E336-47. PubMed ID: 11788365
[TBL] [Abstract][Full Text] [Related]
29. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
[TBL] [Abstract][Full Text] [Related]
30. Translational control of the antiapoptotic function of Ras.
Polunovsky VA; Gingras AC; Sonenberg N; Peterson M; Tan A; Rubins JB; Manivel JC; Bitterman PB
J Biol Chem; 2000 Aug; 275(32):24776-80. PubMed ID: 10811643
[TBL] [Abstract][Full Text] [Related]
31. Eukaryotic initiation factors-4E and -4F stimulate 5' cap-dependent as well as internal initiation of protein synthesis.
Scheper GC; Voorma HO; Thomas AA
J Biol Chem; 1992 Apr; 267(11):7269-74. PubMed ID: 1559971
[TBL] [Abstract][Full Text] [Related]
32. Amino acid availability regulates p70 S6 kinase and multiple translation factors.
Wang X; Campbell LE; Miller CM; Proud CG
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):261-7. PubMed ID: 9693128
[TBL] [Abstract][Full Text] [Related]
33. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
Rousseau D; Kaspar R; Rosenwald I; Gehrke L; Sonenberg N
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1065-70. PubMed ID: 8577715
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
Petegnief V; Font-Nieves M; MartÃn ME; Salinas M; Planas AM
Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
[TBL] [Abstract][Full Text] [Related]
35. Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle.
Kimball SR; Jefferson LS; Fadden P; Haystead TA; Lawrence JC
Am J Physiol; 1996 Feb; 270(2 Pt 1):C705-9. PubMed ID: 8779938
[TBL] [Abstract][Full Text] [Related]
36. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells.
Graves LM; Bornfeldt KE; Argast GM; Krebs EG; Kong X; Lin TA; Lawrence JC
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7222-6. PubMed ID: 7638171
[TBL] [Abstract][Full Text] [Related]
37. Characterization of wild-type and Ser53 mutant eukaryotic initiation factor 4E overexpression in mammalian cells.
Kaufman RJ; Murtha-Riel P; Pittman DD; Davies MV
J Biol Chem; 1993 Jun; 268(16):11902-9. PubMed ID: 8505316
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of eIF-4E on serine 209 by protein kinase C is inhibited by the translational repressors, 4E-binding proteins.
Whalen SG; Gingras AC; Amankwa L; Mader S; Branton PE; Aebersold R; Sonenberg N
J Biol Chem; 1996 May; 271(20):11831-7. PubMed ID: 8662663
[TBL] [Abstract][Full Text] [Related]
39. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
Shu L; Zhang X; Houghton PJ
J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
[TBL] [Abstract][Full Text] [Related]
40. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients.
Grolleau A; Kaplan MJ; Hanash SM; Beretta L; Richardson B
J Clin Invest; 2000 Dec; 106(12):1561-8. PubMed ID: 11120763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
